Brandon Tom: Pioneering Leadership in Specialty Pharmacy and Biopharma Innovation
Inside the Visionary Journey of Orsini Specialty Pharmacy’s President & CEO
Introduction
Brandon Tom is a respected leader in the healthcare and pharmaceutical industry, known for his strategic vision and patient-focused approach. As the President and CEO of Orsini Specialty Pharmacy, he has made a significant impact by steering the company toward innovation in rare disease therapies and gene treatment support. With over 15 years of industry experience, his leadership has brought operational excellence and expanded access to high-touch pharmacy services.
Grounded in a strong academic foundation with degrees from UCLA and the University of the Pacific, Brandon Tom’s journey from pharmacist to executive reflects a deep commitment to both clinical care and commercial strategy. His work continues to influence how specialty pharmacies deliver compassionate, effective care in today’s evolving biopharmaceutical landscape.
Quick Bio
| Key Info | Details |
|---|---|
| Full Name | Brandon Tom |
| Current Role | President & CEO, Orsini Specialty Pharmacy |
| Education | Pharm.D. – University of the Pacific; B.S. – UCLA |
| Industry | Healthcare, Specialty Pharmacy |
| Experience | Over 15 years |
| Residence | Illinois, USA |
| License | Pharmacist – California (non-clinical) |
Brandon Tom’s Educational Foundation and Early Professional Start
His early career saw him working at a national health plan, where he gained foundational experience in health system operations and patient access services. This period helped him understand the practical challenges faced by patients and providers alike, shaping his future approach to leadership in specialty pharmacy.
Rising Through the Ranks at McKesson Corporation
Specialty Strategy and Biologics Management
Brandon Tom’s most prominent career development came during his tenure at McKesson Corporation. He held multiple roles across key business units, including the Group Purchasing Organization (GPO), The US Oncology Network, specialty distribution, and corporate strategy. His strategic vision and operational acumen quickly propelled him into senior leadership positions.
As Vice President and General Manager of Biologics, he led one of the largest portfolios of limited-distribution and exclusive therapy programs. His role involved overseeing therapies that required specialised access models and high-touch patient support—expertise that would prove critical in his next leadership role. During this time, he also collaborated with biopharmaceutical manufacturers, solidifying his experience in product commercialization and specialty drug access.
Leadership at Orsini Specialty Pharmacy
Guiding a Patient-Centric and Rare Disease-Focused Vision
In December 2022, Brandon Tom assumed the role of President and CEO of Orsini Specialty Pharmacy, a leading independent specialty pharmacy provider. At Orsini, he is responsible for setting strategic direction, fostering innovation, and enhancing patient outcomes through high-touch, customized pharmacy solutions.
One of his key focuses has been expanding Orsini’s footprint in the rare disease and gene therapy sectors. Under his leadership, Orsini has secured exclusive distribution rights for several groundbreaking therapies and partnered with leading biopharmaceutical companies to support commercialization strategies. His commitment to patient-centered care is evident in Orsini’s ability to navigate complex reimbursement systems, deliver in-home care solutions, and provide tailored education for patients and caregivers.
Innovative Business Ventures and Strategic Partnerships
Collaboration for Better Patient Outcomes
Beyond his operational duties, Brandon Tom has spearheaded several strategic partnerships aimed at enhancing care delivery. Notably, Orsini partnered with PicnicHealth to improve real-world data collection and patient engagement in the rare disease community. This partnership reflects his vision to integrate technology, data, and human support to advance therapy access and adherence.
Additionally, Orsini’s collaboration with Cycle Pharmaceuticals for the hereditary angioedema treatment SAJAZIR marked a major milestone. These ventures not only expanded Orsini’s portfolio but also reinforced Brandon’s ability to align business goals with clinical excellence.
Commitment to Specialty Pharmacy Excellence
Building Scalable and High-Touch Service Models
Brandon Tom’s leadership is characterized by his focus on scalability and service quality. He has worked tirelessly to ensure that Orsini maintains accreditations from leading organizations such as URAC and The Joint Commission. These certifications validate Orsini’s commitment to quality, safety, and clinical performance—principles Brandon has championed throughout his career.
Moreover, his experience in handling exclusive, high-cost therapies has positioned him as a thought leader in the evolving specialty pharmacy landscape. He advocates for models that go beyond medication dispensing to include wraparound services such as in-home nursing, educational outreach, and emotional support.
Latest Developments and Future Outlook
Driving Growth in Gene Therapy and Ultra-Rare Conditions
In 2025, Orsini continues to grow under Brandon Tom’s guidance. The pharmacy has been selected as an exclusive partner for therapies like VEOPZ for CHAPLE disease and maintains a leadership position in ultra-rare treatment pathways. His strategy revolves around building scalable care infrastructures while preserving the personal touch that patients with rare conditions often require.
Brandon’s future vision includes leveraging AI and real-world evidence to enhance clinical outcomes and predict patient needs more accurately. His goal is not only to grow Orsini’s footprint but also to redefine what quality care looks like in the specialty pharmacy sector.
Legacy and Impact on the Healthcare Industry
Elevating Access and Compassionate Care
Brandon Tom’s legacy is one of innovation, access, and patient advocacy. From McKesson to Orsini, he has built systems that prioritize the patient while enabling business scalability. His contributions to biologics, limited-distribution drugs, and rare disease care have had a measurable impact on thousands of lives.
As an executive, he has demonstrated that growth and compassion can coexist, and that high-touch pharmacy care must evolve alongside emerging therapies. His leadership continues to influence the specialty pharmacy space, making it more inclusive, efficient, and forward-thinking.
Conclusion
Brandon Tom represents a new wave of healthcare leadership—driven by data, centered on people, and grounded in clinical excellence. With a background in pharmacy and a passion for strategy, he has carved out a meaningful role in transforming specialty pharmacy services. His journey from student to CEO is not just a success story, but a blueprint for how healthcare leaders can drive change in complex, high-stakes environments.
Frequently Asked Questions (FAQ)
1. Who is Brandon Tom?
Brandon Tom is the President and CEO of Orsini Specialty Pharmacy and a seasoned healthcare executive with over 15 years of experience.
2. What is his educational background?
He holds a Pharm.D. from the University of the Pacific and a B.S. from UCLA.
3. What does he specialize in?
Brandon specializes in specialty pharmacy services, rare disease therapies, biologics, and commercialization partnerships.
4. What are his major achievements at Orsini?
He has expanded Orsini’s exclusive distribution portfolio, formed key partnerships, and enhanced patient-centered services.
5. What industries has he worked in?
He has worked in healthcare, pharmacy benefit management, specialty drug distribution, and strategic biopharma services.
